Anemia
Video
Sickle cell disease guidelines release set for early 2019
SAN DIEGO – Five new ASH guidelines for sickle cell disease are on the way, likely early in 2019.
Conference Coverage
Opioids appear safe for sickle cell pain
SAN DIEGO – For sickle cell patients, opioid-related mortality is essentially a “never” event.
Video
New treatments promise sickle cell “cure” for all ages
SAN DIEGO – Dr. Ify Osunkwo described the latest approaches, from gene therapy to haploidentical stem cell transplant, as well as patient access...
Conference Coverage
Sickle cell disease phenotype reversed by gene therapy
SAN DIEGO – Genetically modified autologous stem cells increased protective fetal hemoglobin and decreased sickle hemoglobin in an adult with...
Video
Flipping the fetal hemoglobin switch reverses sickle cell symptoms
SAN DIEGO – One adult with sickle cell disease had near-complete remission of symptoms after 6 months of follow-up.
Conference Coverage
Researchers seek more sickle cell drug research
BETHESDA, MD – While there are experimental treatments such as ...
Conference Coverage
Primary care needs pile up for sickle cell patients
BETHESDA, MD. – With people often surviving into middle age with SCD, physicians need to keep in mind the routine complications of aging in these...
Conference Coverage
Sickle cell disease gene therapy seen advancing
BETHESDA, MD. – NIH conference highlights experimental gene therapies for SCD and thalassemia, with further updates on this work slated for ASH’s...
News
FDA approves DNA-based blood type test
This is the first molecular-based test for red blood cell types to report genotypes in its results.
From the Journals
Crizanlizumab relieves sickle cell crises across subgroups
The post hoc analysis of the SUSTAIN trial showed a significant decrease in painful vaso-occlusive crises.
Feature
In Ghana, SCD research is meeting patients on home turf
The West African nation stands ready to solve the geographic mismatch between research capacity and patient population.